A precise temperature control during hyperthermic intraperitoneal chemotherapy promises an early return of bowel function
Introduction The hyperthermic intraperitoneal chemotherapy (HIPEC) has been widely applied in clinical practice for peritoneal carcinomatosis (PC). The temperature is one of the important elements affecting the efficacy of HIPEC, and it can become fluctuant by several factors. This study is aimed to...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-08-01
|
Series: | Cancer Biology & Therapy |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/15384047.2020.1775444 |